摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Cyclohexyl-malonamide | 142917-09-7

中文名称
——
中文别名
——
英文名称
N-Cyclohexyl-malonamide
英文别名
N'-cyclohexylpropanediamide
N-Cyclohexyl-malonamide化学式
CAS
142917-09-7
化学式
C9H16N2O2
mdl
——
分子量
184.238
InChiKey
BHWXYINYYHBIDB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    72.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    N-Cyclohexyl-malonamidetetraphosphorus decasulfide 作用下, 以 1,4-二氧六环 为溶剂, 反应 2.0h, 以33%的产率得到N-cyclohexylmalonodithioamide
    参考文献:
    名称:
    丙二硫代酰胺与乙炔二羧酸酯的反应
    摘要:
    丙二硫代酰胺与乙炔二羧酸酯的反应是在三键处添加硫原子,随后在酯基和氮原子之间发生分子内反应,产生取代的噻唑烷。未取代的丙二硫代酰胺和 N-环己基丙二硫代酰胺产生包含两个硫代酰胺片段的加合物,而 N,N'-双(4-甲氧基苯基)丙二硫代酰胺形成 1:1 的加合物。
    DOI:
    10.1007/s11172-011-0159-y
点击查看最新优质反应信息

文献信息

  • Processes and intermediates for preparing fused heterocyclic kinase inhibitors
    申请人:Raeppel Franck
    公开号:US20090286984A1
    公开(公告)日:2009-11-19
    This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.
    本发明涉及用于制造融合杂环型激酶抑制剂化合物的过程和中间体,例如噻吩吡啶基化合物,并涉及用于制备在制造融合杂环型激酶抑制剂化合物,例如噻吩吡啶基化合物中有用的中间体的过程和中间体,特别是在工业平上。
  • INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
    申请人:Saavedra Oscar Mario
    公开号:US20120083482A1
    公开(公告)日:2012-04-05
    The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds of general formula (A) wherein A 1 is sulfur, A 3 is CH, A 2 is CH, D is heterocycle, Z is oxygen, SO 0-2 or NR, Ar is phenyl and G is not a ring, and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
    本发明涉及抑制VEGF受体信号和HGF受体信号的技术。本发明提供了通式(A)的化合物,其中A1为,A3为CH,A2为CH,D为杂环,Z为氧,SO0-2或NR,Ar为苯基,G不是环,并提供了抑制VEGF受体信号和HGF受体信号的方法。本发明还提供了治疗细胞增殖性疾病和病情的组合物和方法。
  • Beta-carbonyl-carboxyamides of 1,3-thiazolidines
    申请人:BOEHRINGER MANNHEIM ITALIA S.P.A.
    公开号:EP0333080A1
    公开(公告)日:1989-09-20
    Compound of formula I wherein R is hydrogen, C₁-C₄-alkyl, allyl or propargyl; X is O, CH₂ or S; R₁ is a linear or cyclic alkyl, hydroxy, alkoxy, amino group; are useful as antitussive agents.
    式 I 的化合物 其中 R 是氢、C₁-C₄-烷基、烯丙基或丙炔基; X 是 O、CH₂ 或 S; R₁ 是线性或环状烷基、羟基、烷氧基、基; 可用作止咳剂。
  • Non-toxic corrosion-protection pigments based on manganese
    申请人:——
    公开号:US20040011252A1
    公开(公告)日:2004-01-22
    Corrosion-inhibiting pigments based on manganese are described that contain a trivalent or tetravalent manganese/valence stabilizer complex. An inorganic or organic material is used to stabilize the trivalent or tetravalent manganese ion to form a compound that is sparingly soluble, exhibits low solubility, or is insoluble in water, depending upon the intended usage. Specific stabilizers are chosen to control the release rate of trivalent or tetravalent manganese during exposure to water and to tailor the compatibility of the powder when used as a pigment in a chosen binder system. Stabilizers may also modify the processing and handling characteristics of the formed powders. Manganese/valence stabilizer combinations are chosen based on the well-founded principles of manganese coordination chemistry. Many manganese-valence stabilizer combinations are presented that can equal the performance of conventional hexavalent chromium or tetravalent lead systems. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
    为基础的缓蚀颜料含有三价或四价/价稳定剂复合物。一种无机或有机材料可用于稳定三价或四价锰离子,从而形成一种可少量溶解、溶解度低或不溶于的化合物,具体取决于预期用途。选择特定的稳定剂是为了控制三价或四价在遇时的释放率,并调整粉末在所选粘合剂体系中用作颜料时的相容性。稳定剂还可以改变成型粉末的加工和处理特性。/价稳定剂组合的选择是基于配位化学的基本原理。文中介绍了许多价稳定剂组合,其性能与传统的六价或四价体系相当。需要强调的是,提供本摘要是为了符合要求提供摘要的规则,以便检索者或其他读者快速确定技术公开的主题。提交本摘要的前提是,本摘要不用于解释或限制权利要求的范围或含义。
  • Non-toxic corrosion-protection pigments based on rare earth elements
    申请人:——
    公开号:US20040104377A1
    公开(公告)日:2004-06-03
    A corrosion-inhibiting pigment comprising a rare earth element and a valence stabilizer combinded to form a rare earth/valence stabilizer complex. The rare earth element is selected from cerium, terbium, praseodymium, or a combination thereof, and at least one rare earth element is in the tetravalent oxidation state. An inorganic or organic material is used to stabilize the tetravalent rare earth ion to form a compound that is sparingly soluble in water. Specific stabilizers are chosen to control the release rate of tetravalent cerium, terbium, or praseodymium during exposure to water and to tailor the compatibility of the powder when used as a pigment in a chosen binder system. Stabilizers may also modify the processing and handling characteristics of the formed powders. Many rare earth-valence stabilizer combinations are presented that can equal the performance of conventional hexavalent chromium systems.
    一种缓蚀颜料,由稀土元素和价态稳定剂结合形成稀土/价态稳定剂复合物。稀土元素选自或它们的组合,至少有一种稀土元素处于四价氧化态。使用无机或有机材料来稳定四价稀土离子,以形成稀溶于的化合物。选择特定的稳定剂是为了控制四价在遇时的释放率,并调整粉末在所选粘合剂体系中用作颜料时的相容性。稳定剂还可以改变成型粉末的加工和处理特性。本文介绍了许多稀土-价稳定剂组合,其性能可与传统的六价体系媲美。
查看更多